Global Artificial Organ Market, By Organ Type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, Artificial Liver, Others), Material Type (Silicon, Plastics, Steel), Type (Permanent Artificial Organs, Temporary Artificial Organs) – Industry Trends and Forecast to 2030.
Artificial Organ Market Analysis and Size
End-stage renal disease affects over 650,000 patients in the United States each year, with an estimated 2 million patients worldwide (ESRD). End-stage renal disease (ESRD) affects only 1% of the Medicare-covered population but consumes 7% of the Medicare budget. The number of patients diagnosed with end-stage renal disease (ESRD) in the United States rises by 5% each year. The mortality rate varies depending on end-stage renal disease (ESRD) treatment. Dialysis patients have a 20-25% mortality rate after one year of treatment, with a 35% five-year survival rate. After five years, transplant recipients have a 3% mortality rate.
Data Bridge Market Research analyses that the artificial organ market which is USD 23.16 billion in 2022, is expected to reach USD 42.24 billion by 2030, at a CAGR of 7.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Artificial Organ Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Organ Type (Artificial Heart, Artificial Kidney, Artificial Pancreas, Artificial Lungs, Cochlear Implants, Artificial Liver, Others), Material Type (Silicon, Plastics, Steel), Type (Permanent Artificial Organs, Temporary Artificial Organs)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
B. Braun SE (Germany), Boston Scientific Corporation (U.S.), Getinge AB. (Sweden), ABIOMED. (U.S.), Asahi Kasei Corporation (Japan), Berlin Heart (Germany), CARMAT (France), Jarvik Heart, Inc. (U.S.), Terumo Corporation (Japan), SynCardia Systems, LLC (U.S.), Nipro Europe Group Companies (Japan), Medtronic (Ireland), Organovo Holdings Inc. (U.S.), NexImmune (U.S.), Diabeloop SA (France), Admetsys (U.S.), Defymed (France), Pancreum, Inc. (U.S.), Beta Bionics Inc. (U.S.), Integra LifeSciences (U.S.)
|
|
Market Opportunities
|
|
Market Definition
An artificial organ is a man-made organ device or tissue that is implanted or integrated into a human interacting with living tissue to replace a natural organ, duplicate or augment a specific function or functions, and allow the patient to resume normal life as soon as possible. The replaced function is not required to be related to life support, but it is frequently. Replacement bones and joints, such as those used in hip replacements, could be thought of as artificial organs.
Artificial Organ Market Dynamics
Drivers
- Increased R&D activities
Increased product launches, increased R&D activities, and key market players' strategies will drive the segment's growth. Furthermore, new product approvals and ongoing government support are expected to fuel the segment's growth. The FDA granted Abbott Breakthrough Device designation for its in-development Fully Implantable Left Ventricular Assist System in February 2020. In addition, Penn State Health Milton S. Hershey Medical Center will be the country's second hospital to implant a newly designed EvaHeart2 Left Ventricular Assist System (LVAS) in a patient with severe heart failure in March 2021. These are the specific factors that drive market growth.
• Increasing prevalence of organ failure
The increasing prevalence of organ failure due to severe infections, cardiovascular disease, and trauma raises the number of organ transplant surgeries. The World Health Organization reported 48.9 million cases of sepsis in 2019. Bad habits, such as drinking and smoking, can lead to liver and heart failure. As the prevalence of such diseases increases, so does the risk of organ failure, increasing demand for artificial organs.
Opportunities
• Advances in 3D Bioprinting
Advances in 3D bioprinting have proven critical in organ transplantation because it is used to create artificial organs. 3D bioprinting is becoming increasingly popular because it reduces the risk of organ rejection. Furthermore, artificial intelligence is poised to change global trends in the use of artificial devices. Many countries are focusing on developing a tool that provides a personalised assessment of organ and donor suitability. This tool will be extremely useful in making informed decisions about organ retrieval and deciding whether patients should accept donor organs or wait for better options.
Restraints/Challenges
- Lack of skilled professionals
A lack of skilled professionals, transplant side effects such as skin irritation, high procedure costs, low technology penetration in developing countries, and other factors is hampering the artificial organ market. The disease's presence in the base tissue used to create the organ is a major concern. The tissue may already be infected with another disease in such cases. Growing and transplanting an artificial organ is prohibitively expensive, limiting its use to the general public. The risk of organ failure is high, and the body may need time to adjust to the new organ.
This artificial organ market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the artificial organ market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Artificial Organ Market
The demand for COVID-19 vaccine has increased due to an increase in daily cases worldwide. As a result, the demand for rapid diagnostic testing has increased. For instance, according to much research, real time PCR (RT-PCR) is the most inexpensive and effective method for diagnosing COVID-19 testing. The unexpected emergence of the COVID-19 pandemic prompted the implementation of stringent lockdown regulations in several countries, resulting in the postponement of elective surgeries to combat the risk of coronavirus infection. Doctors need a properly functioning operation theatre that is free of infection for artificial organ implants, and because of Covid-19, this criteria has become even more difficult, hampered the market.
Recent Developments
Global Artificial Organ Market Scope
The artificial organ market is segmented on the basis of organ type, material type and type. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Organ Type
- Artificial Heart
- Prosthetic heart valves
- Ventricular assist devices
- Cardiac pacemakers
- Artificial Kidney
- Artificial Pancreas
- Artificial Lungs
- Cochlear Implants
- Artificial Liver
- Others
Material Type
- Silicon
- Plastics
- Steel
Type
- Permanent Artificial Organs
- Temporary Artificial Organs
Artificial Organ Market Regional Analysis/Insights
The artificial organ market is analyzed and market size insights and trends are provided by country, organ type, material type and type as referenced above.
The countries covered in the artificial organ market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the artificial organ market due to rising cases of organ failure and the increasing ageing population in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to increasing healthcare expenditure and improvement in the healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Artificial Organ Market Share Analysis
The artificial organ market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to artificial organ market.
Some of the major players operating in the artificial organ market are:
- B. Braun SE (Germany)
- Boston Scientific Corporation (U.S.)
- Getinge AB. (Sweden)
- ABIOMED. (U.S.)
- Asahi Kasei Corporation (Japan)
- Berlin Heart (Germany)
- CARMAT (France)
- Jarvik Heart, Inc. (U.S.)
- Terumo Corporation (Japan)
- SynCardia Systems, LLC (U.S.)
- Nipro Europe Group Companies (Japan)
- Medtronic (Ireland)
- Organovo Holdings Inc. (U.S.)
- NexImmune (U.S.)
- Diabeloop SA (France)
- Admetsys (U.S.)
- Defymed (France)
- Pancreum, Inc. (U.S.)
- Beta Bionics Inc. (U.S.)
- Integra LifeSciences (U.S.)
SKU-